Longevity & AgingReview ArticlePaywall

How Oxidized SOD1 May Drive Skin Aging Through Proteostasis Collapse

A key antioxidant enzyme, when oxidized by ROS, may trigger a self-amplifying cycle of protein damage and cellular senescence in aging skin.

Saturday, September 5, 2026 6 views
Published in Ageing Res Rev
Close-up of aged human skin on the back of a hand beside a laboratory diagram of a protein misfolding, with a test tube and molecular model on a lab bench

Summary

Superoxide dismutase 1 (SOD1) is a critical antioxidant enzyme that neutralizes superoxide radicals in skin cells. This review explores what happens when SOD1 itself becomes damaged by reactive oxygen species (ROS) through a process called post-translational oxidation. When oxidized, SOD1 misfolds and forms toxic protein aggregates, undermining the cell's protein quality-control systems — a state called proteostasis collapse. In skin cells like dermal fibroblasts, this breakdown triggers a vicious cycle: more oxidative stress, more damaged proteins, mitochondrial dysfunction, cellular senescence, and chronic low-grade inflammation. Together these processes degrade the extracellular matrix, leading to wrinkles, reduced elasticity, and weakened skin barrier function. The authors propose SOD1 oxidation as a promising therapeutic target for counteracting skin aging at the molecular level.

0:00--:--

Detailed Summary

Skin is the body's outermost shield, constantly bombarded by UV radiation, pollution, and other oxidative stressors. As we age, the skin's capacity to manage this oxidative load declines, but the molecular mechanisms linking reactive oxygen species (ROS) to visible skin aging remain incompletely understood. This review, published in Ageing Research & Reviews, focuses on a specific and underappreciated culprit: the post-translational oxidation of superoxide dismutase 1 (SOD1).

SOD1 is a copper- and zinc-dependent enzyme that serves as a frontline cellular defense against superoxide radicals. Paradoxically, SOD1 is itself vulnerable to oxidative modification by the very species it is designed to neutralize. When ROS chemically alter SOD1's structure after it is produced, the enzyme misfolds and can aggregate into toxic protein species. This disrupts the cell's proteostasis network — the system responsible for maintaining proper protein folding, repair, and clearance.

In dermal fibroblasts and epidermal cells, this proteostasis collapse has compounding consequences. The review describes a bidirectional feedback loop between proteostasis failure and mitochondrial dysfunction: damaged mitochondria produce more ROS, which oxidize more SOD1, which further impairs protein homeostasis. This self-reinforcing cycle drives cellular senescence and chronic low-grade inflammation (inflammaging), ultimately causing extracellular matrix degradation — the biological basis of wrinkles, sagging, and impaired barrier function.

The authors are careful to distinguish well-established skin-specific evidence from hypotheses extrapolated from other biological systems, lending conceptual rigor to the framework. They position the SOD1 proteotoxic axis as a candidate therapeutic target, opening the door to interventions — potentially including small molecules, antioxidants, or protein-quality-control enhancers — that could intercept this cycle.

Caveats apply: this is a narrative review based on existing literature, with no new experimental data. Causal relationships in human skin aging remain to be confirmed in dedicated clinical studies.

Key Findings

  • Oxidized SOD1 misfolds into toxic aggregates, initiating a self-amplifying cycle of superoxide accumulation and protein damage in skin cells.
  • Proteostasis collapse and mitochondrial dysfunction form a bidirectional feedback loop that accelerates cellular senescence and inflammaging.
  • These converging processes degrade extracellular matrix, producing wrinkles, reduced elasticity, and compromised skin barrier function.
  • SOD1 oxidation is proposed as a novel candidate therapeutic target for pharmacological or nutraceutical intervention in skin aging.
  • The review rigorously separates skin-specific evidence from extrapolations made from non-cutaneous biological systems.

Methodology

This is a narrative review article synthesizing existing literature on ROS-mediated post-translational modifications of SOD1, proteostasis, and cutaneous aging. No new experimental data were generated. The authors explicitly distinguish skin-specific evidence from mechanistic hypotheses derived from other biological systems.

Study Limitations

This summary is based on the abstract only, as the full text is not open access. The review is a narrative synthesis without meta-analytic quantification, and the causal role of SOD1 oxidation specifically in human cutaneous aging has not been confirmed by prospective clinical trials or interventional studies.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: